Sarah Finley
Head of DMPK

Sarah earned a PhD in Pharmacology and Toxicology at University of Illinois at Urbana‑Champaign, where she studied drug interactions mediated by cytochrome P-450 enzyme systems. She has worked in the field of drug metabolism, pharmacokinetics, and clinical pharmacology for more than 25 years, and her former employers include Pfizer, Theravance, Clovis Oncology, and Menlo Therapeutics. She has been an independent consultant providing bioanalysis, DMPK, and clinical pharmacology strategy/execution/regulatory filing/advisory committee meeting support for small and mid-size biopharmaceutical companies since 2009.